Amgen Inc on Monday set the U.S. list price for its new Evenity osteoporosis dru...
- Amgen Inc on Monday set the U.S. list price for its new Evenity osteoporosis drug at $1,825 a month, or $21,900 for a full 12-month course of injections.
The U.S. Food and Drug Administration last week approved bone-building Evenity for postmenopausal women who are at high risk of fracture, but required the label to have a boxed warning, the FDA’s strictest, flagging increased risk of heart attack, stroke and cardiovascular-related death. Analysts, on average, project Amgen’s Evenity revenue at $274 million a year by 2024, according to IBES data from Refinitiv.
Evenity, part of a new class of drugs known as sclerostin inhibitors, was studied in large clinical trials for one year, and the FDA said its use should be limited to one year.
इंडिया ताज़ा खबर, इंडिया मुख्य बातें
Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।
New Jersey high school principal dies donating bone marrowA high school principal has died donating bone marrow to someone in need. Derrick Nelson, 44, the principal of Westfield High School in Westfield, New Jersey, died April 8 after falling to into a coma during a procedure to donate bone marrow to a 14-year-old boy in France, Nelson’s father told ABC News
और पढो »
New Jersey high school principal dies donating bone marrowDerrick Nelson was the principal at Westfield High School in New Jersey.
और पढो »
In Philippine cave, scientists find bones and teeth belonging to a new human speciesScientists have uncovered bones and teeth belonging to a new human species that lived in Callao Cave in the Philippines more than 50,000 years ago.
और पढो »
Bones discovered in an island cave may be a new human speciesThe group of human species includes Neanderthals, ourselves and, scientists say, a unusual sort of oddball named Homo luzonensis.
और पढो »
Perspective | The perils of value-based pricing for prescription drugsHow do you determine the value, and the price, of lifesaving medication?
और पढो »
Watch: Pharmacy middlemen testify at Senate drug price hearing
और पढो »
Health stocks plunge as uncertainty rises on Obamacare, Congress threatens action on drug pricesHealth-care stocks were poised to end the week in the red after lawmakers on Capitol Hill threatened to take legislative action against the nation's largest pharmacy benefit mangers on rising prescription high drug costs.
और पढो »
CVS, Cigna, Humana blame Big Pharma for high drug prices in Senate hearingExecutives from the nation's largest pharmacy benefit managers denied that so-called 'backdoor deals' with drug manufacturers are responsible for the high prices patients pay for drugs.
और पढो »
Sanofi sets a fixed price of insulin at $99 per month for some patientsThe move is a pre-emptive one as the French drugmaker is set to testify before the House Energy and Commerce Committee on the rising prices of insulin later in the day.
और पढो »